We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
(+4.1%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$182M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$170M |
| 3 |
AET
Aetna Inc
AET
|
+$131M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$108M |
| 5 |
Brookdale Senior Living
BKD
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$435M |
| 2 |
Elevance Health
ELV
|
+$121M |
| 3 |
Cigna
CI
|
+$119M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$82.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.34% |
| 2 | Financials | 7.86% |
| 3 | Consumer Discretionary | 7.17% |
| 4 | Technology | 6.32% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
NVR
NVR
$16.5B
| $362K | 0.01% |
+270
| New | +$364K |
|
727
Delek US
DK
$4.16B
| $358K | 0.01% |
9,728
+3,803
| +64% | +$143K |
|
728
Community Bank
CBU
$3.41B
| $357K | 0.01% |
9,459
+1,726
| +22% | +$62K |
|
|
DCOM
729
DELISTED
Dime Community Bancshares
DCOM
| $357K | 0.01% |
21,055
+542
| +3% | +$8.91K |
|
730
M&T Bank
MTB
$35.7B
| $355K | 0.01% |
2,844
-294
| -9% | -$36.2K |
|
|
CTXS
731
DELISTED
Citrix Systems Inc
CTXS
| $355K | 0.01% |
6,351
+547
| +9% | +$29.1K |
|
732
American Water Works
AWK
$26.7B
| $354K | 0.01% |
7,280
+18
| +0.2% | +$947 |
|
|
AEGN
733
DELISTED
Aegion Corp
AEGN
| $354K | 0.01% |
+18,700
| New | +$344K |
|
734
United Parks & Resorts
PRKS
$2.1B
| $353K | 0.01% |
+19,146
| New | +$397K |
|
|
SNI
735
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $353K | 0.01% |
5,401
-5,033
| -48% | -$343K |
|
|
ADT
736
DELISTED
ADT Corp
ADT
| $349K | ﹤0.01% |
+10,400
| New | +$396K |
|
|
JAH
737
DELISTED
JARDEN CORPORATION
JAH
| $347K | ﹤0.01% |
6,703
-5,185
| -44% | -$274K |
|
738
DexCom
DXCM
$31.5B
| $345K | ﹤0.01% |
+17,232
| New | +$303K |
|
739
SITE Centers
SITC
$225M
| $342K | ﹤0.01% |
+17,182
| New | +$381K |
|
740
CenterPoint Energy
CNP
$27.7B
| $340K | ﹤0.01% |
+17,881
| New | +$362K |
|
|
SGYP
741
CALL
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $340K | ﹤0.01% |
+1,030
| New | +$4.99K |
|
742
L3Harris
LHX
$51.6B
| $338K | ﹤0.01% |
4,400
+1,404
| +47% | +$111K |
|
|
PCP
743
DELISTED
PRECISION CASTPARTS CORP
PCP
| $338K | ﹤0.01% |
1,690
+590
| +54% | +$124K |
|
|
JOY
744
DELISTED
Joy Global Inc
JOY
| $337K | ﹤0.01% |
+9,300
| New | +$374K |
|
|
PCL
745
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $335K | ﹤0.01% |
8,248
-500
| -6% | -$21K |
|
|
ABMD
746
DELISTED
Abiomed Inc
ABMD
| $334K | ﹤0.01% |
+5,086
| New | +$338K |
|
|
CVC
747
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $334K | ﹤0.01% |
13,968
-23,628
| -63% | -$513K |
|
|
ACOR
748
DELISTED
Acorda Therapeutics
ACOR
| $333K | ﹤0.01% |
83
-978
| -92% | -$3.78M |
|
749
Hancock Whitney
HWC
$6.2B
| $332K | ﹤0.01% |
10,397
+2,905
| +39% | +$88.1K |
|
750
Lockheed Martin
LMT
$134B
| $330K | ﹤0.01% |
1,775
-33,225
| -95% | -$6.4M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
- Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
- Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
- Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
- Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
- Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
- Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.
Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.